Actionable news
All posts from Actionable news
Actionable news in REGN: Regeneron Pharmaceuticals, Inc.,

Regeneron Pharmaceuticals (REGN) Leonard S. Schleifer, M.D., Ph.D. on Q3 2015 Results - Earnings Call Transcript


Good day, ladies and gentlemen, and welcome to the Regeneron Pharmaceuticals Third Quarter 2015 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. As a reminder, this call may be recorded.

I would now like to turn the conference over to Dr. Michael Aberman, Senior Vice President of Strategy and Investor Relations with Regeneron. You may begin.

Michael Aberman, M.D. - Senior Vice President, Strategy and Investor Relations

Thank you, operator. Good morning, everybody, and welcome to Regeneron Pharmaceuticals' third quarter 2015 conference call. An archive of this webcast will be available on our website under Events and Presentations for 30 days.

Joining me on the call today are Dr. Leonard Schleifer, Founder, President and Chief Executive Officer; Dr. George Yancopoulos, Founding Scientist, President of Regeneron Laboratories and Chief Scientific Officer; Bob Terifay, Senior Vice President, Commercial; and Bob Landry...